Calibrating the Regulatory Clock

Confidence: hypothesis. The failures below are drawn from published research on forecasting and widely reported industry patterns, not firsthand deployment. The pattern at the end is an argument, not a shipped system. Argue with it.

Some of the most important dates in a project are set by other people. A regulator's approval. A partner's sign-off. A third party's delivery. You do not control these clocks, but your timeline depends on them, so you have to forecast them. And the usual way teams forecast a dependency they do not control is to guess, optimistically, and then act surprised when the guess is wrong in the same direction it is always wrong.

Choosing which countries a trial runs in is full of these clocks. Each country brings a regulatory authority with its own pace and its own habits. The global start waits on the slowest one you picked. So the quality of your timeline depends on how well you forecast a set of clocks you cannot speed up.

The clinical why

A trial cannot begin in a country until that country's authority clears it. Those authorities differ enormously. Some move quickly and ask predictable questions. Some are slow. Some require a local study before they will consider the global one. When a program picks its countries, it is also picking a set of approval timelines, and the whole global schedule gates on whichever authority it chose carelessly.